 BALA CYNWYD, Pa., Nov. 21, 2022 GLOBE NEWSWIRE -- Larimar Therapeutics, Inc. Larimar Nasdaq: LRMR, a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that company management will present and participate in 1x1 investor meetings at the 34th Annual Piper Sandler Healthcare Conference, which is taking place in New York, NY from November 29 December 1, 2022. The Companys presentation will take place on Thursday, December 1, 2022, at 10:10 AM ET. 